Isracann Biosciences Inc. filed its Annual on Nov 30, 2022 for the period ending May 31, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -.--% | -100.00% | -100.00% |
Apr. 26 | Isracann Biosciences Inc. Announces Resignation of Directors | CI |
Jan. 23 | Isracann Biosciences Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 1.95M | |
+45.15% | 6.38B | |
-14.00% | 4.59B | |
+9.54% | 3.39B | |
-8.99% | 3.2B | |
+50.03% | 2B | |
-6.97% | 1.7B | |
-0.31% | 1.65B | |
+50.00% | 1.55B | |
-10.61% | 1.58B |
- Stock Market
- Equities
- IPOT Stock
- News Isracann Biosciences Inc.
- Isracann Biosciences Inc. Auditor Raises 'Going Concern' Doubt